Vitalum通过AI医疗产品和VAM交易所上市扩大叙事，但缺少公开收入、DAO、审计和临床验证，使成熟度仍停留在38.3%。
Investment View
关键信号不是价格，而是执行证据。只有公开VAM支付使用量、奖励资金来源、归属透明度和医疗AI验证，早期叙事才能转化为经济成熟度。
Source PDF
The PDF report is available alongside the slide viewer.
Report Type
Project Maturity Analysis
Version
v1
Analysis Date
2026年8月4日
Language
zh
Disclaimer: This report is generated through AI-powered analysis and market data. This is not investment advice. All investment decisions should be made at your own risk.